검색결과 : 4건
| No. | Article |
|---|---|
| 1 |
Involvement of MCL1, c-myc, and cyclin D2 protein degradation in ponatinib-induced cytotoxicity against T315I(+) Ph+leukemia cells Inoue C, Sobue S, Kawamoto Y, Nishizawa Y, Ichihara M, Abe A, Hayakawa F, Suzuki M, Nozawa Y, Murate T Biochemical and Biophysical Research Communications, 525(4), 1074, 2020 |
| 2 |
Identification of ponatinib and other known kinase inhibitors with potent MEKK2 inhibitory activity Ahmad S, Johnson GL, Scott JE Biochemical and Biophysical Research Communications, 463(4), 888, 2015 |
| 3 |
Predicting the Impact of Deleterious Mutations in the Protein Kinase Domain of FGFR2 in the Context of Function, Structure, and Pathogenesis-a Bioinformatics Approach Rajith GPDCB, Chakraborty C Applied Biochemistry and Biotechnology, 170(8), 1853, 2013 |
| 4 |
Efficacy of ponatinib against ABL tyrosine kinase inhibitor-resistant leukemia cells Okabe S, Tauchi T, Tanaka Y, Ohyashiki K Biochemical and Biophysical Research Communications, 435(3), 506, 2013 |